The Tubal She Chose

It is post-operative day one. The repeat cesarean from yesterday afternoon went well — clean incision, anticipated blood loss, baby is healthy. The bilateral tubal ligation that we performed alongside it is, in operative terms, a routine addition to the procedure, two small clips applied to two anatomically straightforward structures, two-minute add-on, no separate consent risk under federal regulation because the thirty-day waiting requirement was met by her prenatal-visit signature.

I sit at the side of her bed in the morning. She has the baby on her chest. Her partner is in the chair next to the bed, reading something on his phone. She is awake enough to talk. She is exhausted in the way that the day after a third cesarean produces exhaustion — not the new exhaustion of new motherhood, but the deeper kind that is also relief.

This is the conversation about permanent contraception, on the morning after permanent contraception. I do it every time. Not because I doubt the decision — the consent for the bilateral tubal ligation was signed thirty-one days ago at the twenty-eight-week prenatal visit, and the patient and I had the same conversation then that we are having now — but because the federal regulation that requires the thirty-day wait was written in 1979 in response to a documented institutional pattern of unconsented sterilization of poor and Black and Native women in state hospitals, and the regulation's protective intent is honored by the post-operative confirmation that the decision the woman signed for is still the decision she made. The regulation is also, in operational practice, the regulation that prevents approximately half of the Medicaid-insured women who request a postpartum tubal ligation from receiving it during their delivery admission, because the thirty-day-prior consent was never signed.

She tells me, in the morning, what she had told me at twenty-eight weeks. That she is forty-two. That this is her fourth pregnancy and her third living child. That she does not want to be pregnant again. That she had been on an intrauterine device for the eight years before this pregnancy and that the IUD had been the easiest birth-control she had ever used, but that the IUD had eventually expired and her insurance situation had been such that the replacement had been complicated and the unplanned conception had occurred in the gap. That, in the present federal environment, she does not trust that the contraceptive access she had used for the previous decade will be reliably available for the next decade. That she is choosing permanence because the system she lives in has, for the past three years, taught her that the system's promises about contraception cannot be relied on.

This is the operational reality of contraception in a country where Title X is being administratively starved, where the Comstock framework is being judicially reopened, where the four corporate pharmacy chains that fill seventy percent of outpatient prescriptions have, in the post-Dobbs environment, made stocking decisions that vary by state and by chain counsel. The patient at forty-two with three living children and an expired IUD is rational to assume that her future contraceptive access depends on a system that is contracting. The decision to make the contraception permanent is, in the strict decision-theory sense, a rational response to a probabilistic environment in which the alternative future-access pathways are foreclosing.

I can do the procedure. I can do the post-operative conversation. I can do the documentation that the consent process was honored at every step. I can, in the chart, write the sentence that explains why the patient made the choice she made — not in terms that imply the decision was anything other than freely made, but in terms that make visible the system-level context inside which the decision was made.

What I cannot do, at her bedside, is undo the federal-administrative environment that produced the decision. The Title X clinic she would have gone to for the eight years between her tubal and her menopause is the clinic whose funding stream was frozen this spring. The IUD-replacement encounter that, in 2018, took fifteen minutes and one visit, is the encounter that in 2026 may, depending on her insurance status and her state of residence, take three visits and four months and a counseling appointment and a follow-up call. The decision she has made was, in some part, made for her by the system her tubal ligation is now her response to.

I tell her what I tell every postpartum patient on the morning after a tubal. That the procedure is done. That the consent was honored. That she is welcome to call me, or any of my colleagues, in three months or three years if there is anything she wants to discuss about what comes next. I do not tell her — because the bedside is not the place for it — that the conversation she and I just had is, in operational terms, the contemporary descendant of a regulatory regime that was written in response to a documented atrocity and that is now operating, in part, as the access barrier that pushes the same population toward permanence as the rational decision. The decision was hers. The context was not.